MSNBC Hallie Jackson Reports February 11, 2022 20:24:00
Pfizer to submit their two dose data to them for authorization, they said in part this afternoon that the fda felt it was their responsibility as a public health agency to act with urgency and have all available options including they provide us with initial data on two doses from the on going study, their goal was to understand if two dose was provide sufficient protection. remember, we had press release information already in december from pfizer that said, you know, there two dose regimen in this age-group did not trigger a comparable immune response as what was seen in 16 to 25-year-olds. ...
Source: archive.org
